These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26524749)

  • 1. The True Environmental Cost of Chlorofluorocarbon-Based Inhalers.
    Swenson ER
    JAMA Intern Med; 2015 Nov; 175(11):1867. PubMed ID: 26524749
    [No Abstract]   [Full Text] [Related]  

  • 2. On Chlorofluorocarbon Bans and Inhaled Albuterol Prices.
    Ross JS; Redberg RF
    JAMA Intern Med; 2015 Jul; 175(7):1179. PubMed ID: 25962127
    [No Abstract]   [Full Text] [Related]  

  • 3. Not Breathing Easier With the US FDA's Ban on Chlorofluorocarbons in Inhalers.
    Redberg RF
    JAMA Intern Med; 2015 Jul; 175(7):1086. PubMed ID: 25961435
    [No Abstract]   [Full Text] [Related]  

  • 4. The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma.
    Jena AB; Ho O; Goldman DP; Karaca-Mandic P
    JAMA Intern Med; 2015 Jul; 175(7):1171-9. PubMed ID: 25962128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of bronchodilator medication in priming a conventional metered dose inhaler: a cost of treating asthma.
    Ross RN
    Med Interface; 1997 Apr; 10(4):141-6. PubMed ID: 10166801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Copayment Changes on Children's Albuterol Inhaler Use and Costs after the Clean Air Act Chlorofluorocarbon Ban.
    Galbraith AA; Fung V; Li L; Butler MG; Nordin JD; Hsu J; Smith D; Vollmer WM; Lieu TA; Soumerai SB; Wu AC
    Health Serv Res; 2018 Feb; 53(1):156-174. PubMed ID: 27868200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.
    Langley PC
    Clin Ther; 1999 Jan; 21(1):236-53. PubMed ID: 10090438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler.
    Desager KN; van Bever HP; Vermeire PA
    Lancet; 1996 Jul; 348(9021):200-1. PubMed ID: 8684181
    [No Abstract]   [Full Text] [Related]  

  • 9. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DTCA and the cost of asthma inhalers.
    Saunders B
    N Z Med J; 2003 Nov; 116(1185):U672. PubMed ID: 14615810
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The environmental impact of chlorofluorocarbon use in metered dose inhalers.
    Balmes JR
    Chest; 1991 Oct; 100(4):1101-2. PubMed ID: 1914565
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol.
    Chrystyn H
    Br J Clin Pharmacol; 1996 Aug; 42(2):257-8. PubMed ID: 8864330
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma.
    Walley T; Bundred P; Rannard A; Bogg J
    Postgrad Med J; 1999 Dec; 75(890):710-4. PubMed ID: 10567594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low cost spacer device used for asthma treatment in a Calcutta street clinic to improve efficacy of metered dose inhalers.
    Kerac M; Montgomery H; Johnson N
    Trop Doct; 1998 Oct; 28(4):228-9. PubMed ID: 9803846
    [No Abstract]   [Full Text] [Related]  

  • 16. The economic effect of the hydrofluoroalkane albuterol transition on children with asthma.
    Leo HL; Dombkowski KJ; Clark NM
    J Allergy Clin Immunol; 2008 Mar; 121(3):776-7. PubMed ID: 18328895
    [No Abstract]   [Full Text] [Related]  

  • 17. Counseling about chlorofluorocarbon-free inhalers.
    Breitigan JM
    Am J Health Syst Pharm; 1998 Feb; 55(3):226-7. PubMed ID: 9492253
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
    Bronsky E; Ekholm BP; Klinger NM; Colice GL
    J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness of environmental issues and the acceptance of CFC-free inhalers.
    Goh SY; Arulanandam S; Ho CL; Zhang L; Goh DY; Chew FT; Lee BW
    Ann Trop Paediatr; 1998 Sep; 18(3):225-30. PubMed ID: 9924560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing for a change in metered-dose inhalers. National Asthma Education and Prevention Program CFC Phaseout Working Group.
    Minn Med; 1998 Feb; 81(2):26-7. PubMed ID: 9505495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.